It is FDA-approved for individuals with a BMI of 30 or greater, or a BMI of 27 or above with weight-related health conditions
Skin sensitivity: an emerging signal Skin burning and abnormal touch sensitivity (dysesthesia) appears as a dose-related, reversible signal in two case series and post-market surveillance. Trials did not pre-specify it, and the tirzepatide label does not list it
Genetic factors affecting your GLP-1 receptor expression and FTO gene variants influence how sensitively your body responds, making personalized assessment essential for long-term success
Whether brand-name or compounded from a licensed 503A pharmacy, semaglutide activates the same GLP-1 receptors, so overdose risks and symptoms are identical
For rapid relief, glycerol suppositories may be considered
GLP-1 medication can slow transit throughout the digestive system